Dexmedetomidine can provide cardioprotective effect in laparoscopic hysterectomy patients.

A randomized controlled study of dexmedetomidine given cardioprotective effect of laparoscopic hysterectomy patients.

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-14004732

Enrollment

Unknown

Registered

2014-06-01

Start date

2014-06-03

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myocardial injury

Interventions

Open group:15ml saline

Pneumoperitoneum group:15ml saline

Eligibility

Sex/Gender

Female

Age

44 Years to 80 Years

Inclusion criteria

Inclusion criteria: Class ASA I-II, in elderly patients (aged 45 years and elder), no significant preoperative lung, liver and kidney dysfunction anesthesia hysterectomy surgery patients.

Exclusion criteria

Exclusion criteria: Long-term alcoholics smoke, severe kidney disease, diabetes, cardiopulmonary disease, long-term use sedative drugs, patients with history of mental illness, bradycardia and atrioventricular block.

Design outcomes

Primary

Measure	Time frame
People ischemia-modified albumin;	—

Countries

China

Contacts

Public ContactZhang Ye

Second Affiliated Hospital of Anhui Medical University

zhangye_hassan@sina.com+86 13966768081

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026